CCL11 and Alzheimer disease: Two proteins were significantly different after FDR correction when comparing AD patients and healthy controls; transforming growth factor-α (TGF-α, FDR: 0.020) from plasma samples and Eotaxin (CCL11, FDR: 0.024) from EV samples.